The Food and Drug Administration of the Philippines had issued a warning to the public against off-label uses such as whitening
But since the medication has not specifically been tested for that purpose, taking a medication off-label comes with risks
State-level Medicaid coverage indicates whether an individual state includes obesity-indicated GLP-1s (Saxenda, Wegovy, and Zepbound) or Type 2 diabetes-indicated GLP-1s (Ozempic, Mounjaro, and Rybelsus) on its formulary or preferred drug list, including non-preferred or restricted coverage
Bedtime injection timing mitigates nausea and flushing by allowing peak side effects (which occur 13 hours post-injection) to coincide with sleep, when they are not consciously perceived
Medical factors contributing to plateaus include suboptimal dosing, weight-promoting concurrent medications, underlying endocrine disorders, and medication non-adherence